- Home
- PYPD vs CSTE Comparison
PYPD vs CSTE Comparison
Compare PYPD & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- CSTE
- Stock Information
- Founded
- PYPD 2008
- CSTE 1987
- Country
- PYPD Israel
- CSTE Israel
- Employees
- PYPD N/A
- CSTE N/A
- Industry
- PYPD Medical/Dental Instruments
- CSTE Building Materials
- Sector
- PYPD Health Care
- CSTE Industrials
- Exchange
- PYPD Nasdaq
- CSTE Nasdaq
- Market Cap
- PYPD 54.7M
- CSTE 61.9M
- IPO Year
- PYPD 2020
- CSTE 2012
- Fundamental
- Price
- PYPD $3.80
- CSTE $1.17
- Analyst Decision
- PYPD Strong Buy
- CSTE
- Analyst Count
- PYPD 5
- CSTE 0
- Target Price
- PYPD $12.00
- CSTE N/A
- AVG Volume (30 Days)
- PYPD 92.7K
- CSTE 87.2K
- Earning Date
- PYPD 11-12-2025
- CSTE 11-12-2025
- Dividend Yield
- PYPD N/A
- CSTE N/A
- EPS Growth
- PYPD N/A
- CSTE N/A
- EPS
- PYPD N/A
- CSTE N/A
- Revenue
- PYPD N/A
- CSTE $406,178,000.00
- Revenue This Year
- PYPD N/A
- CSTE N/A
- Revenue Next Year
- PYPD N/A
- CSTE $5.61
- P/E Ratio
- PYPD N/A
- CSTE N/A
- Revenue Growth
- PYPD N/A
- CSTE N/A
- 52 Week Low
- PYPD $2.30
- CSTE $1.17
- 52 Week High
- PYPD $3.93
- CSTE $5.04
- Technical
- Relative Strength Index (RSI)
- PYPD 68.11
- CSTE 27.29
- Support Level
- PYPD $3.10
- CSTE $1.20
- Resistance Level
- PYPD $3.50
- CSTE $1.48
- Average True Range (ATR)
- PYPD 0.18
- CSTE 0.10
- MACD
- PYPD 0.06
- CSTE -0.03
- Stochastic Oscillator
- PYPD 94.87
- CSTE 0.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).